BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23483190)

  • 1. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
    Zheng X; Gai X; Wu Z; Liu Q; Yao Y
    Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
    Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
    BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
    PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zheng X; Song T; Dou C; Jia Y; Liu Q
    Oncotarget; 2015 Feb; 6(6):3752-69. PubMed ID: 25686837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
    Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN
    Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition.
    Chen H; Jia W; Li J
    World J Surg Oncol; 2016 Jul; 14(1):195. PubMed ID: 27460906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
    Xiao H; Jiang N; Zhou B; Liu Q; Du C
    Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
    Han LL; Jia L; Wu F; Huang C
    Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.